CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 62 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $32,000 | +14.3% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $28,000 | +21.7% | 1,500 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $23,000 | +9.5% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $21,000 | -55.3% | 1,500 | -50.0% | 0.00% | -62.5% |
| Q3 2020 | $47,000 | -11.3% | 3,000 | 0.0% | 0.01% | -20.0% |
| Q2 2020 | $53,000 | +20.5% | 3,000 | 0.0% | 0.01% | +11.1% |
| Q1 2020 | $44,000 | -41.3% | 3,000 | 0.0% | 0.01% | -35.7% |
| Q4 2019 | $75,000 | +66.7% | 3,000 | 0.0% | 0.01% | +55.6% |
| Q3 2019 | $45,000 | -40.0% | 3,000 | 0.0% | 0.01% | -40.0% |
| Q2 2019 | $75,000 | – | 3,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 479,681 | $21,484,912 | 8.12% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $6,315,390 | 7.68% |
| STEMPOINT CAPITAL LP | 551,095 | $24,683,545 | 7.25% |
| EcoR1 Capital, LLC | 4,155,375 | $186,119,246 | 5.69% |
| ACUTA CAPITAL PARTNERS, LLC | 135,141 | $6,052,965 | 5.10% |
| First Light Asset Management, LLC | 1,200,508 | $53,770,753 | 4.71% |
| Ikarian Capital, LLC | 588,818 | $26,373,158 | 4.59% |
| Paradigm Biocapital Advisors LP | 2,513,302 | $112,570,797 | 4.31% |
| MPM BioImpact LLC | 557,184 | $24,956,271 | 3.88% |
| Cormorant Asset Management, LP | 1,350,000 | $60,466,500 | 3.49% |